Portfolio Companies

  • AI/ML Ops
    Architecture, Engineering, and Construction
    B2B GTM
    B2C MarTech & Customer Support
    BioTech/Therapeutics
    Consumer
    Cybersecurity
    Data & Data Mgmt.
    DevOps
    eCommerce Enablement
    Education
    Energy & Climate
    Finance & Accounting
    Financial Services
    Gaming
    Government
    Healthcare
    Human Capital
    IT Mgmt
    Legal & Compliance
    Manufacturing
    Marketplace
    Other Vertical Market SaaS
    Payments
    Product & Process Management
    Real Estate
    Supply Chain & Logistics
    Web3
  • North America
    Africa
    Western Europe
    Eastern Europe
    Asia Pacific
    Israel
    South America
  • Current Investment
    Prior Investment

Limerick, No Data Available, Ireland

Amsterdam, No Data Available, Netherlands

Tel Aviv, No Data Available, Israel

Bonn, No Data Available, Germany

Miami, Florida, U.S.

San Francisco, California, U.S.

Insight Partners is an awesome firm that shares many of our values, and we’ve been grateful to have them as partners on this journey of building a great company based on a great product.
Eran Zinman
Co-Founder & CEO Monday.com*

London, No Data Available, U.K.

Lehi, Utah, U.S.

Farmington, Utah, U.S.

Espressive logo

San Francisco, California, U.S.

Wilmington, North Carolina, U.S.

San Francisco, California, U.S.

Founded in 2019, Qualifyze is a leading company in supply chain risk management in the Life Sciences industry, trusted by over 1,200 pharmaceutical and healthcare companies globally. Its suite of digital solutions connects manufacturers, suppliers, and a global network of more than 250 auditors and quality experts for a more streamlined collaboration. With a track record of over 3,000 audits across 85+ countries and the largest and most accurate supplier network and data analytics tools, Qualifyze stands as the all-in-one partner for quality compliance and supply chain risk management processes in the Life Sciences sector.

Investment Team Ryan Hinkle Alessandro Luciano Jonathan Rosenbaum
Sectors Healthcare Pharma
Status Current Investment